Cytokinetics, Incorporated

NasdaqGS:CYTK Stok Raporu

Piyasa değeri: US$6.8b

Cytokinetics Yönetim

Yönetim kriter kontrolleri 3/4

Cytokinetics CEO'su Robert Blum, Feb2006 tarihinde atandı, in görev süresi 18.75 yıldır. in toplam yıllık tazminatı $ 8.75M olup, şirket hissesi ve opsiyonları dahil olmak üzere 9% maaş ve 91% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.23% ine doğrudan sahiptir ve bu hisseler $ 15.86M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.6 yıl ve 14 yıldır.

Anahtar bilgiler

Robert Blum

İcra Kurulu Başkanı

US$8.8m

Toplam tazminat

CEO maaş yüzdesi9.0%
CEO görev süresi18.8yrs
CEO sahipliği0.2%
Yönetim ortalama görev süresi3.6yrs
Yönetim Kurulu ortalama görev süresi14yrs

Son yönetim güncellemeleri

Recent updates

Cytokinetics: Aficamten Rolling NDA Submission Leads To Expansion Opportunities

Aug 13

Is Cytokinetics (NASDAQ:CYTK) Weighed On By Its Debt Load?

Aug 11
Is Cytokinetics (NASDAQ:CYTK) Weighed On By Its Debt Load?

Cytokinetics' Aficamten: Heartfelt Potential Amid Market Woes

Jul 24

Cytokinetics Decides To Go It Alone

May 24

Here's Why We Think Cytokinetics, Incorporated's (NASDAQ:CYTK) CEO Compensation Looks Fair for the time being

May 09
Here's Why We Think Cytokinetics, Incorporated's (NASDAQ:CYTK) CEO Compensation Looks Fair for the time being

Cytokinetics, Incorporated: Buyout Speculation Persists

Apr 01

Cytokinetics: CEO Talks Down Buyout Prospects

Mar 16

Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade)

Jan 12

An Intrinsic Calculation For Cytokinetics, Incorporated (NASDAQ:CYTK) Suggests It's 37% Undervalued

Oct 05
An Intrinsic Calculation For Cytokinetics, Incorporated (NASDAQ:CYTK) Suggests It's 37% Undervalued

CEO Tazminat Analizi

Robert Blum'un ücretlendirmesi Cytokinetics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$576m

Jun 30 2024n/an/a

-US$545m

Mar 31 2024n/an/a

-US$531m

Dec 31 2023US$9mUS$790k

-US$526m

Sep 30 2023n/an/a

-US$527m

Jun 30 2023n/an/a

-US$540m

Mar 31 2023n/an/a

-US$431m

Dec 31 2022US$9mUS$742k

-US$389m

Sep 30 2022n/an/a

-US$282m

Jun 30 2022n/an/a

-US$216m

Mar 31 2022n/an/a

-US$258m

Dec 31 2021US$6mUS$709k

-US$215m

Sep 30 2021n/an/a

-US$229m

Jun 30 2021n/an/a

-US$156m

Mar 31 2021n/an/a

-US$135m

Dec 31 2020US$5mUS$682k

-US$127m

Sep 30 2020n/an/a

-US$114m

Jun 30 2020n/an/a

-US$140m

Mar 31 2020n/an/a

-US$132m

Dec 31 2019US$3mUS$656k

-US$122m

Sep 30 2019n/an/a

-US$118m

Jun 30 2019n/an/a

-US$110m

Mar 31 2019n/an/a

-US$105m

Dec 31 2018US$3mUS$630k

-US$106m

Sep 30 2018n/an/a

-US$120m

Jun 30 2018n/an/a

-US$131m

Mar 31 2018n/an/a

-US$132m

Dec 31 2017US$3mUS$612k

-US$128m

Tazminat ve Piyasa: Robert 'ın toplam tazminatı ($USD 8.75M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 7.88M ).

Tazminat ve Kazançlar: Robert şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Robert Blum (60 yo)

18.8yrs

Görev süresi

US$8,751,057

Tazminat

Mr. Robert I. Blum has been Chief Executive Officer, President and Director of Cytokinetics, Incorporated since January 22, 2007 and served as its Principal Financial Officer until May 08, 2024. Mr. Blum p...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Robert Blum
CEO, President & Director18.8yrsUS$8.75m0.23%
$ 15.9m
Robert Wong
VP & Chief Accounting Officer5.5yrsUS$1.04m0.0063%
$ 433.1k
Fady Malik
Executive Vice President of Research & Development12.4yrsUS$4.44m0.054%
$ 3.7m
Andrew Callos
Executive VP & Chief Commercial Officer3.7yrsUS$3.20m0.021%
$ 1.4m
James Spudich
Co-Founder & Member of Scientific Advisory Board27.3yrsUS$21.94kVeri yok
Sung Lee
Executive VP & CFOless than a yearVeri yokVeri yok
Jeff Lotz
Vice President of Sales & Operations3.2yrsVeri yokVeri yok
Matt Yang
Vice President of Corporate Finance and Financial Planning & Analysisless than a yearVeri yokVeri yok
Steven Cook
Senior Vice President of Global Supply Chain Operations & Technical Operationsno dataVeri yokVeri yok
Kari Loeser
VP & Chief Compliance Officer3yrsVeri yokVeri yok
John Faurescu
VP, Associate General Counsel & Corporate Secretaryno dataVeri yokVeri yok
Scott Jordan
Senior Vice President of Global Marketing & Commercial Strategy3.5yrsVeri yokVeri yok

3.6yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim: CYTK 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.6 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Robert Blum
CEO, President & Director17.8yrsUS$8.75m0.23%
$ 15.9m
James Spudich
Co-Founder & Member of Scientific Advisory Boardno dataUS$21.94kVeri yok
B. Parshall
Independent Director11.8yrsUS$529.02k0.013%
$ 869.7k
Santo Costa
Independent Director14yrsUS$524.02k0.013%
$ 869.7k
James H. Sabry
Co-Founder & Chairman of Scientific Advisory Board16.6yrsUS$41.50kVeri yok
Nancy Wysenski
Independent Director4yrsUS$519.02k0.015%
$ 1.0m
John Henderson
Independent Chairman15.8yrsUS$559.02k0.028%
$ 1.9m
John Lowe
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Thomas Pollard
Member of Scientific Advisory Boardno dataVeri yokVeri yok
David Morgans
Member of Scientific Advisory Board8.3yrsUS$942.23kVeri yok
Lawrence S. Goldstein
Member of Scientific Advisory Boardno dataVeri yokVeri yok
John Solaro
Member of Scientific Advisory Boardno dataVeri yokVeri yok

14.0yrs

Ortalama Görev Süresi

70.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CYTK 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 14 yıldır).